SE442015B - SET TO MAKE BUFADIENOLID AND BUFATRIENOLIDETERS - Google Patents
SET TO MAKE BUFADIENOLID AND BUFATRIENOLIDETERSInfo
- Publication number
- SE442015B SE442015B SE7806364A SE7806364A SE442015B SE 442015 B SE442015 B SE 442015B SE 7806364 A SE7806364 A SE 7806364A SE 7806364 A SE7806364 A SE 7806364A SE 442015 B SE442015 B SE 442015B
- Authority
- SE
- Sweden
- Prior art keywords
- solution
- mmol
- titanium tetrachloride
- carbon atoms
- dioxane
- Prior art date
Links
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 43
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 claims description 33
- 239000003054 catalyst Substances 0.000 claims description 18
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims description 15
- -1 alkyl radical Chemical class 0.000 claims description 14
- 239000004327 boric acid Substances 0.000 claims description 14
- 125000004432 carbon atom Chemical group C* 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 9
- KTXWGMUMDPYXNN-UHFFFAOYSA-N 2-ethylhexan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCC(CC)C[O-].CCCCC(CC)C[O-].CCCCC(CC)C[O-].CCCCC(CC)C[O-] KTXWGMUMDPYXNN-UHFFFAOYSA-N 0.000 claims description 5
- 229910052719 titanium Inorganic materials 0.000 claims description 5
- 239000010936 titanium Substances 0.000 claims description 5
- JMXKSZRRTHPKDL-UHFFFAOYSA-N titanium ethoxide Chemical compound [Ti+4].CC[O-].CC[O-].CC[O-].CC[O-] JMXKSZRRTHPKDL-UHFFFAOYSA-N 0.000 claims description 5
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- YBPMPRDOWHIVNA-XTBIJCDISA-N bufadienolide Chemical compound C=1([C@H]2CC[C@@H]3[C@H]4[C@@H]([C@]5(CCCCC5CC4)C)CC[C@@]32C)C=CC(=O)OC=1 YBPMPRDOWHIVNA-XTBIJCDISA-N 0.000 claims description 4
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 4
- HAJGVUYNXHQLER-UHFFFAOYSA-N Bufadienolide Natural products O1C(=O)C=CC(C2C3C(C4C(C5CCCCC5CC4)CC3)CC2)=C1 HAJGVUYNXHQLER-UHFFFAOYSA-N 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 125000000853 cresyl group Chemical group C1(=CC=C(C=C1)C)* 0.000 claims description 2
- 239000012442 inert solvent Substances 0.000 claims description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Chemical compound CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 claims 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 1
- WBLIXGSTEMXDSM-UHFFFAOYSA-N chloromethane Chemical compound Cl[CH2] WBLIXGSTEMXDSM-UHFFFAOYSA-N 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 125000003700 epoxy group Chemical group 0.000 claims 1
- 150000002170 ethers Chemical class 0.000 claims 1
- TZMFJUDUGYTVRY-UHFFFAOYSA-N ethyl methyl diketone Natural products CCC(=O)C(C)=O TZMFJUDUGYTVRY-UHFFFAOYSA-N 0.000 claims 1
- 229930182470 glycoside Natural products 0.000 claims 1
- 150000002338 glycosides Chemical class 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 24
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 10
- 238000001953 recrystallisation Methods 0.000 description 10
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 5
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- RYSXWUYLAWPLES-MTOQALJVSA-N (Z)-4-hydroxypent-3-en-2-one titanium Chemical compound [Ti].C\C(O)=C\C(C)=O.C\C(O)=C\C(C)=O.C\C(O)=C\C(C)=O.C\C(O)=C\C(C)=O RYSXWUYLAWPLES-MTOQALJVSA-N 0.000 description 2
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 230000029936 alkylation Effects 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Chemical group C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- HJTAZXHBEBIQQX-UHFFFAOYSA-N 1,5-bis(chloromethyl)naphthalene Chemical compound C1=CC=C2C(CCl)=CC=CC2=C1CCl HJTAZXHBEBIQQX-UHFFFAOYSA-N 0.000 description 1
- BCEBOAVUYVQOIR-UHFFFAOYSA-N 1-chloro-2-diazoethane Chemical compound ClCC=[N+]=[N-] BCEBOAVUYVQOIR-UHFFFAOYSA-N 0.000 description 1
- XAROELXRWZQTTG-UHFFFAOYSA-N 1-diazo-2-methoxyethane Chemical compound COCC=[N+]=[N-] XAROELXRWZQTTG-UHFFFAOYSA-N 0.000 description 1
- ZSKNZBAJUNEUJA-UHFFFAOYSA-N 1-diazo-3-methoxypropane Chemical compound COCCC=[N+]=[N-] ZSKNZBAJUNEUJA-UHFFFAOYSA-N 0.000 description 1
- BZWJDKJBAVXCMH-UHFFFAOYSA-N 1-diazopropane Chemical compound CCC=[N+]=[N-] BZWJDKJBAVXCMH-UHFFFAOYSA-N 0.000 description 1
- IUWXVUQWEZTBCT-UHFFFAOYSA-N 3-[(z)-diazomethyl]heptane Chemical compound CCCCC(CC)C=[N+]=[N-] IUWXVUQWEZTBCT-UHFFFAOYSA-N 0.000 description 1
- NWWZHYJYBALBGJ-UHFFFAOYSA-N 3-diazo-N,N-dimethylpropan-1-amine Chemical compound CN(C)CCC=[N+]=[N-] NWWZHYJYBALBGJ-UHFFFAOYSA-N 0.000 description 1
- CTZFBSDRSZNOBE-UHFFFAOYSA-N 3-diazoprop-1-yne Chemical compound [N-]=[N+]=CC#C CTZFBSDRSZNOBE-UHFFFAOYSA-N 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- PZIQGAZNKPSARD-UHFFFAOYSA-N [(2z)-2-diazoethyl]benzene Chemical compound [N-]=[N+]=CCC1=CC=CC=C1 PZIQGAZNKPSARD-UHFFFAOYSA-N 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- SMZOGRDCAXLAAR-UHFFFAOYSA-N aluminium isopropoxide Chemical compound [Al+3].CC(C)[O-].CC(C)[O-].CC(C)[O-] SMZOGRDCAXLAAR-UHFFFAOYSA-N 0.000 description 1
- GOLCXWYRSKYTSP-UHFFFAOYSA-N arsenic trioxide Inorganic materials O1[As]2O[As]1O2 GOLCXWYRSKYTSP-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000005997 bromomethyl group Chemical group 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229960002089 ferrous chloride Drugs 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- NMCUIPGRVMDVDB-UHFFFAOYSA-L iron dichloride Chemical compound Cl[Fe]Cl NMCUIPGRVMDVDB-UHFFFAOYSA-L 0.000 description 1
- 125000006203 morpholinoethyl group Chemical group [H]C([H])(*)C([H])([H])N1C([H])([H])C([H])([H])OC([H])([H])C1([H])[H] 0.000 description 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J19/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring
- C07J19/005—Glycosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Catalysts (AREA)
- Steroid Compounds (AREA)
Description
7806364-1 10 15 20 25A 2 Det för detta förfarande utmärkande är, att en bufadienolid eller bufatrienolid med den allmänna formeln e (II) OH ¶“O Cda \ OH där X och R' har den angivna betydelsen, omsättes med en díazoalkan med den allmänna formeln ' (111) R.CH.N2 i ett inert lösningsmedel och i närvaro av en svagt sur kataly- sator. 7806364-1 10 15 20 25A 2 The characteristic of this process is that a bufadienolide or bufatrienolide of the general formula e (II) OH ¶ „O Cda \ OH where X and R 'have the indicated meaning, is reacted with a diazoalkane with the general formula '(111) R.CH.N2 in an inert solvent and in the presence of a weakly acid catalyst.
Som svagt sura katalysatorer nämnes järn(IIl)klorid i eter, bortrifluoriddieterat, borsyraestrar, aluminiumklorid, alumini- umisopropylat, p-toluensulfonsyra, polyfosforsyra i eter, arse- niktríoxid, titantetraklorid, molybden(VI)oxiklorid, tenndiklo- rid, tennsulfat, koppar(II)k1oríd men företrädesvis borsyra el- ålerdm-borsyra.Slightly acidic catalysts include ferrous chloride in ether, boron trifluoride diethylate, boric acid esters, aluminum chloride, aluminum isopropylate, p-toluenesulfonic acid, polyphosphoric acid in ether, arsenic trioxide, titanium tetrachloride, molybdenum (VI) tenene sulphonyl chloride, (II) chloride but preferably boric acid or boric acid.
Det_har nu överraskande nog visat sig, att utbytet av 3'- alkyleter kan förbättras väsentligt om man enligt föreliggande uppfinning som katalysator använder en blandning av titantetra- kloríd och borsyra eller av titantetraklorid och en ester av titansyra med en alífatisk eller aromatisk alkohol i absolut dioxan och om radikalen R betecknar alkenyl eller etynyl med två kolatomer, grenad alkyl med 6 kolatomer,_fenylmety1 eller 2-fenyletyl, dimetylaminoalkyl med 1 eller 2 kolatomer i alkyl- delen, morfolinoetyl, tetrahydro-2-furfuryl, klormetyl eller brometyl, då radikalen X betecknar en dubbelbíndníng och radi- kalen R' betecknar metyl, R betecknar väte eller metyl, då X betecknar en dubbclbindníng och R' betecknar metylol eller R betecknar väte, rak eller grenad alkyl med 1-6 kolatomer, vinyl, 10 15 20 25 5 30 35 7806364-1 3 etynyl, alkoxi med 2-4 kolatomer, 2-fenyletyl, dietylamino, N- morfolinoetylzellerfklor- eller bromsubstituerad alkyl med 1 eller 2 kolatomer, då X betecknar en epoxigrupp och R' beteck- nar metyl.It has now surprisingly been found that the yield of 3 'alkyl ether can be substantially improved if, according to the present invention, a mixture of titanium tetrachloride and boric acid or of titanium tetrachloride and an ester of titanium acid with an aliphatic or aromatic alcohol in absolute dioxane is used as catalyst. and if the radical R represents alkenyl or ethynyl having two carbon atoms, branched alkyl having 6 carbon atoms, phenylmethyl or 2-phenylethyl, dimethylaminoalkyl having 1 or 2 carbon atoms in the alkyl moiety, morpholinoethyl, tetrahydro-2-furfuryl, chloromethyl or bromomethyl, then the radical X represents a double bond and the radical R 'represents methyl, R represents hydrogen or methyl, when X represents a double bond and R' represents methylol or R represents hydrogen, straight or branched alkyl having 1-6 carbon atoms, vinyl, 7806364-1 ethynyl, alkoxy having 2-4 carbon atoms, 2-phenylethyl, diethylamino, N-morpholinoethylcellular or chloro-substituted alkyl having 1 or 2 carbon atoms, when X represents an ep oxy group and R 'represents methyl.
Som titansyraestrar ifrågakommer etyltitanat, n-propyl-, isoprcpyl-, n-butyl-, isobutyl-, kresyl-, 2-etylhexyltitanat och díisopropoxi-bis-(2,4-pentandíonato)-titan(IV) (= titan-I acetylacetonat).Examples of titanium acid esters are ethyl titanate, n-propyl, isopropyl, n-butyl, isobutyl, cresyl, 2-ethylhexyl titanate and diisopropoxy-bis- (2,4-pentanedionate) -titanium (IV) (= titanium I-acetylacetone ).
Fördelen med dessa katalysatorer ligger i, att alkylering- en i 3'-ställning sker selektivt och att i motsats till vid bor- syra enbart mindre mängder opolära produkter (dimetyleter) bil- das. Omsättningen sker långsammare än med borsyra och är därför mera selektiv och kvantitativ.The advantage of these catalysts is that the alkylation in the 3 'position takes place selectively and that, in contrast to boric acid, only smaller amounts of non-polar products (dimethyl ether) are formed. Sales are slower than with boric acid and are therefore more selective and quantitative.
Det har vidare fastställts, att man ej uppnår samma effekt med samma koncentration titantetraklorid enbart som katalysator eller med samma koncentration titanester enbart som med en blandning av båda. Även en blandning av titantetraklorid och borsyra verkar mera selektivt på alkyleringen med diazoalkaner än titantetraklorid eller borsyra enbart. Reaktionshastigheten avtager i följande ordníngsföljd: titantetrakloríd, borsyra, titantetraklorid och borsyra.It has further been found that the same effect is not obtained with the same concentration of titanium tetrachloride alone as catalyst or with the same concentration of titanium ester alone as with a mixture of both. Also a mixture of titanium tetrachloride and boric acid acts more selectively on the alkylation with diazoalkanes than titanium tetrachloride or boric acid alone. The reaction rate decreases in the following order: titanium tetrachloride, boric acid, titanium tetrachloride and boric acid.
Uppfinningen åskådliggöres närmare under hänvisning till följande exempel.The invention is further illustrated by reference to the following examples.
Exemgel 1. 2 g 3ß(u,L-rammnosido)-14-hydroxi-4,5-epoxi-bufa- 20,22-dienolíd löses i 100 ml absolut dioxan och försättes med en lösning av diazometan i eter (0,5 mmol/ml). Sedan tillsätter man 4 ml av en katalysatorlösning av 0,1 mmol borsyra och 0,005 mmol titantetraklorid/ml i absolut díoxan. Lösningen får stå 4- 5 h vid rumstemperatur, överskottet diazometan avfärgas med någ- radroppar isättika, indunstas försiktigt i vakuum och återsto- den upptages i kloroform. Lösningen skakas en gång med en Z-pro- centig natríumbikarbonatlösníng och två gånger med vatten, tor- kas över vattenfritt natriumsulfat, avfiltreras och indunstas i vakuum. Återstoden omkristalliseras flera gånger ur metanol-vat- ten, varvid 95-98 % ren 38-0-(a,L-3'-metylramnosido)-14-hydroxi- 4,5-epoxi-bufa-20,22-dienolid med smältpunkten 220-232°C erhål- les.Example gel 1. 2 g of 3β (u, L-frame nosido) -14-hydroxy-4,5-epoxy-bufa-20,22-dienolide are dissolved in 100 ml of absolute dioxane and added with a solution of diazomethane in ether (0.5 mmol / ml). Then 4 ml of a catalyst solution of 0.1 mmol of boric acid and 0.005 mmol of titanium tetrachloride / ml in absolute dioxane are added. The solution is allowed to stand for 4 to 5 hours at room temperature, the excess diazomethane is decolorized with a few drops of glacial acetic acid, carefully evaporated in vacuo and the residue is taken up in chloroform. The solution is shaken once with a 2% sodium bicarbonate solution and twice with water, dried over anhydrous sodium sulphate, filtered off and evaporated in vacuo. The residue is recrystallized several times from the methanol-water, 95-98% pure 38-O- (α, L-3'-methylramnosido) -14-hydroxy-4,5-epoxy-bufa-20,22-dienolide with melting point 220-232 ° C is obtained.
Katalysatorlösníngen framställes på följande sätt: I en mät- kolv på 100 ml löses 0,62 g (10 mmol) borsyra í cirka 50-60 ml 7806364-1 :-.... 10' 15 20 25 30 35 4 absolut dioxan. Till denna lösning sättes 10 ml av en lösning av titantetraklorid i absolut dioxan (0,05 mmol/ml); dvs 0,55 ml titantetraklorid/100 ml absolut díoxan) och påfylles med ab- solut dioxan till graderingen. Lösningen innehåller 0,1 mmol borsyra och 0,005 mmol titantetraklorid/ml. Den i början gulfär- gade lösningen blir efter någon tid färglös. Lösningen är håll- bar i flera dygn vid rumstemperatur. _ Exempel 2. 2 g 35-0-(u,L-ramnosido)-14-hydroxí-bufa-4,20,22-trí- enolid löses i 80 ml absolut dioxan och försättes med en lösning av 2-etyldiazohexan (0,8 mmol/ml) i eter. Till lösningen sättes ytterligare 4 ml av en katalysatorblandning av 0,05 mmol n-pro- pyltítanat och 0,005 mmol titantetraklorid/ml i dioxan. Reak- tionsblandningen lämnas att stå 16 h vid rumstemperatur och vi- darebehandlas enligt exempel 1. Genom omkristallísation ur me- tanol-vatten erhålles 90 % ren 3B-O-[a,L-3'-(2"-etylhexyl)-ram- nosído]-14-hydroxi-bufa-4,20,22-trienolíd med smältpunkten 235- 241°c.The catalyst solution is prepared as follows: In a 100 ml volumetric flask, 0.62 g (10 mmol) of boric acid are dissolved in about 50-60 ml of absolute dioxane. To this solution is added 10 ml of a solution of titanium tetrachloride in absolute dioxane (0.05 mmol / ml); ie 0.55 ml titanium tetrachloride / 100 ml absolute dioxane) and make up to the grade with absolute dioxane. The solution contains 0.1 mmol boric acid and 0.005 mmol titanium tetrachloride / ml. The initially yellow solution becomes colorless after some time. The solution is stable for several days at room temperature. Example 2. 2 g of 35-O- (u, L-ramnosido) -14-hydroxy-bufa-4,20,22-tri-enolide are dissolved in 80 ml of absolute dioxane and added with a solution of 2-ethyldiazohexane (0 .8 mmol / ml) in ether. To the solution is added an additional 4 ml of a catalyst mixture of 0.05 mmol of n-propyl titanate and 0.005 mmol of titanium tetrachloride / ml in dioxane. The reaction mixture is allowed to stand for 16 hours at room temperature and further treated according to Example 1. Recrystallization from methanol-water gives 90% pure 3B-O- [a, L-3 '- (2 "-ethylhexyl) -ram nosido] -14-hydroxy-bufa-4,20,22-trienolide, m.p. 235-241 ° C.
Katalysatorlösningen framställes genom att man löser 0,35 ml n-propyltitanat i en mätkolv på 25 ml i cirka hälften av vo- lymen i absolut dioxan och sedan tillsätter 2,5 ml av en titan- tetrakloridlösning i dioxan (0,05 mmol/ml, se exempel 1) och kompletterar till 25 ml.The catalyst solution is prepared by dissolving 0.35 ml of n-propyl titanate in a 25 ml volumetric flask in about half the volume of absolute dioxane and then adding 2.5 ml of a titanium tetrachloride solution in dioxane (0.05 mmol / ml , see Example 1) and make up to 25 ml.
Exempel 3. 2 g 33-0-(a,L-ramnosido)-24-hydroxi-bufa-4,20,22-tri- enolid löses i 80 ml absolut dioxan och försättes med 11 ml av en lösning av 2-klordiazoetan (0,7 mmol/ml). Till lösningen sät- *tes 4 ml av blandkatalysatorn borsyra/titantetraklorid enligt exempel 1 och lämnas att stå i 4-6 h. Härpå vidarebehandlas en- ligt exempel 1 och efter omkristallisation ur ättiksyraetyles- ter erhålles med 95-procentigt utbyte 36-0-[u,L-3'-(2"-kloretyl)- ramnosido]-14-hydroxi-bufa-4,20,22-trienolid med smältpunkten, 168-17s°c.Example 3. 2 g of 33-O- (α, L-ramnosido) -24-hydroxy-bufa-4,20,22-trienolide are dissolved in 80 ml of absolute dioxane and added to 11 ml of a solution of 2-chlorodiazoethane (0.7 mmol / ml). To the solution was added 4 ml of the mixed catalyst boric acid / titanium tetrachloride according to Example 1 and left to stand for 4-6 hours. It was then further treated according to Example 1 and after recrystallization from acetic acid ethyl ester obtained with a 95% yield. [u, L-3 '- (2 "-chloroethyl) -ramnosido] -14-hydroxy-bufa-4,20,22-trienolide, m.p. 168-17 ° C.
Exempel 4. 1 g 36-0-(a,L-ramnosído)-14-hydroxi-bufa-4,20,22- trienolid löses i 40 ml absolut díoxan och försättes med 15 ml av en lösning av 3-(2-etyl)-hexyloxidiazopropan-(1) (0,6 mmol/9 ml) i eter. Till reaktionslösningen sätter man Z ml av en n-pro- pyltitanat- (0,0S mmol/ml) och titantetraklorid- (0,005 mmol/ml) -lösning enligt exempel 2 och lämnar att stå 16 h vid rumstempe- ratur. Sedan vidarebehmxflas lösningen enligt exempel 1 och efter 'omkristallisation ur ättiksyraetylester erhålles 1,1 g (85 %) 10 15 20 25 30 7806364-1 5 ren 330-[o,L-3'-(3"-(T"-ety1)-hexyloxípropyll-ramnosido]-14- hydroxi-bufa-4,20,22-trienolid med smältpunkten 225-2300C.Example 4. 1 g of 36-O- (α, L-rhamnosido) -14-hydroxy-bufa-4,20,22-trienolide is dissolved in 40 ml of absolute dioxane and added to 15 ml of a solution of 3- (2- ethyl) -hexyloxidiazopropane- (1) (0.6 mmol / 9 ml) in ether. To the reaction solution is added Z ml of an n-propyl titanate (0.0S mmol / ml) and titanium tetrachloride (0.005 mmol / ml) solution according to Example 2 and left to stand for 16 hours at room temperature. Then the solution according to Example 1 is further carried out and after recrystallization from acetic acid ethyl ester, 1.1 g (85%) of pure 330- [0,1-L '3' - (3 "- (T" -ethyl) are obtained. ) -hexyloxypropyl-ramnosido] -14-hydroxy-bufa-4,20,22-trienolide, m.p.
Exempel 5.'3 g 3ß-0-(a,L-ramnosido)-14-hydroxi-4,5-epoxi-bufa- 20,22-dienolid löses i 160 ml absolut dioxan och försättes med 50 ml av en eterlösning av diazometan (0,6 mmol/ml). Man till- sätter 1 ml av en etyltitanat-titantetrakloridlösning i absolut dioxan (0,05 mmol etyltitanat och 0,005 mmol titantetrakloríd/ml) och låter stå 4-6 h vid rumstemperatur. Efter vidarebehandling enligt exempel 1 erhålles efter omkristallisation ur metano1-vat- ten 3,5 g (93 %) ren 36-0-(o,L-3'-etylramnosido)-14-hydroxi-4,5- epoxi-zo,zz«bufad1en01id med smä1rpunkren 136-14s°c.Example 5. '3 g of 3β-O- (α, L-ramnosido) -14-hydroxy-4,5-epoxy-bufa-20,22-dienolide are dissolved in 160 ml of absolute dioxane and added to 50 ml of an ether solution of diazomethane (0.6 mmol / ml). Add 1 ml of an ethyl titanate-titanium tetrachloride solution in absolute dioxane (0.05 mmol ethyl titanate and 0.005 mmol titanium tetrachloride / ml) and leave for 4-6 hours at room temperature. After further treatment according to Example 1, after recrystallization from methanol-water, 3.5 g (93%) of pure 36-O- (o, L-3'-ethylramnosido) -14-hydroxy-4,5-epoxy-zo are obtained. zz «bufad1en01id med smä1rpunkren 136-14s ° c.
Exempel 6. 2 g 36-0-(o,L-ramnosido)-14~hydroxi-4,S-epoxi~bufa- 20,22-dienolid löses i 50 ml absolut dioxan och försättes med 13 ml av en lösning av diazopropan (0,4 mmol/ml) i eter. Sedan tillsätter man 4 ml av en lösning av i-propyltítanat (0,05 mmol/ ml) i titantetraklorid (0,005 mmol/ml) i dioxan. Lösningen får stå 3-4 h vid rumstemperatur. Efter vidarebehandling enligt ex- empel 1 erhålles efter omkristallisation ur metanol-vatten 2,1 g (96 %) ren 36-O-(o,L-3'-propylramnosido)-14-hydroxi-4,5-epoxi- bufa-20,22-dienolid med smäirpunkten 230-z3s°c.Example 6. 2 g of 36-O- (0,1-L-ramnosido) -14-hydroxy-4,5-epoxy-bufa-20,22-dienolide are dissolved in 50 ml of absolute dioxane and added to 13 ml of a solution of diazopropane (0.4 mmol / ml) in ether. Then 4 ml of a solution of i-propyl titanate (0.05 mmol / ml) in titanium tetrachloride (0.005 mmol / ml) in dioxane are added. The solution is allowed to stand for 3-4 hours at room temperature. After further treatment according to Example 1, after recrystallization from methanol-water, 2.1 g (96%) of pure 36-O- (0,1'-3'-propylramnosido) -14-hydroxy-4,5-epoxy-bufa- 20,22-dienolide with a melting point of 230 ° C.
Katalysatorlösníngen framställes genom att 0,35 ml i-propyl- titanat löses i en mätkolv på 25 ml i något absolut dioxan och 2,5 ml av en títantetrakloridlösning (0,05 mmol/ml), se exempel 1) i dioxan (absolut) tillsättes, varefter påfylles till grade- ringen med absolut dioxan.The catalyst solution is prepared by dissolving 0.35 ml of i-propyl titanate in a 25 ml graduated flask in some absolute dioxane and 2.5 ml of a titanium tetrachloride solution (0.05 mmol / ml), see Example 1) in dioxane (absolute) is added, after which it is made up to the grade with absolute dioxane.
*Exempel 7. 2 g 36-0-(o,L-ramnosído]-14-hydroxi-4,S-epoxí-bufa- dienolid löses i 50 ml absolufldioxan och försättes med 63 ml av en lösning av 3-metoxidíazopropan (0,8 mmol/ml) i eter. Till lösningen sätter man en katalysatorlösníng av i-butyltitanat (0,05 mmol/ml) och titantetraklorid (0,005 mmol/ml) i dioxan.Example 7. 2 g of 36-O- (O, L-ramnosido) -14-hydroxy-4,5-epoxy-bufadienolide are dissolved in 50 ml of absolute an dioxane and added to 63 ml of a solution of 3-methoxydiazopropane (0 .8 mmol / ml) in ether To the solution is added a catalyst solution of i-butyl titanate (0.05 mmol / ml) and titanium tetrachloride (0.005 mmol / ml) in dioxane.
Efter 12 h vid rumstemperatur vídarebehandlas enligt exempel 1 och efter omkristallisatíon ur etanol-vatten erhåller man 2,16 g (95 %] ren 36-0-(d,L-3'-metoxípropylramnosído)-14-hydroxí-4,5- epoxi-bufa-20,2Z-dienolid med smältpunkten 225-Z40°C.After 12 hours at room temperature further treated according to Example 1 and after recrystallization from ethanol-water, 2.16 g (95%] of pure 36-O- (d, L-3'-methoxypropylramnosido) -14-hydroxy-4,5- epoxy-bufa-20,2Z-dienolide with melting point 225-Z40 ° C.
Katalysatorlösningon framställes genom att man löser 0,43 ml i-butyltitanat i en mätkolv på 25 ml i något absolut dioxan och tillsätter 2,5 ml av en titantetrakloridlösning (0,05 mmol/ ml enligt exempel 1) och påfyller díoxan upp till graderíngen. 7806364-1 10 15 20 25, g 25 ml löser 0,78 ml 2~etylhexyltítanat i något absolut dioxan 30 35 6 Éiempel 8. 2 g 36-0-(u,L-ramnosido)-14-hydroxi-4,5-epoxi-bufa- 20,22-dienolid löses i 50 ml absolut dioxan och försättes med 25 ml av en lösning av 2-metoxidiazoetan (0,3 mmol/ml) i eter.The catalyst solution is prepared by dissolving 0.43 ml of i-butyl titanate in a 25 ml volumetric flask in some absolute dioxane and adding 2.5 ml of a titanium tetrachloride solution (0.05 mmol / ml according to Example 1) and adding dioxane up to the gradient. 7806364-1 10 15 20 25, g 25 ml dissolve 0.78 ml of 2-ethylhexyl titanate in some absolute dioxane Example 35 2 g 36-O- (u, L-ramnosido) -14-hydroxy-4,5 -epoxy-bufa-20,22-dienolide is dissolved in 50 ml of absolute dioxane and added with 25 ml of a solution of 2-methoxydiazoethane (0.3 mmol / ml) in ether.
Till lösningen sättes 4 ml av en blandning av kresyltitanat och' títantetraklorid (0,4 % kresyltitanat och 0,005 ml titantetra- klorid/ml) i dioxan. Lösningen får stå 16 h vid rumstemperatur.To the solution is added 4 ml of a mixture of cresyl titanate and titanium tetrachloride (0.4% cresyl titanate and 0.005 ml titanium tetrachloride / ml) in dioxane. The solution is allowed to stand for 16 hours at room temperature.
Efter vidarebehandling enligt exempel 1 erhålles efter omkrís- tallisatíon ur metanol-vatten 2,15 g (95 %) ren 5ß~0-(a,L-3'- metoxi-etylramnosido)-14-hydroxi-4,5-epoxi-bufa-20,22-dienolid med smäifpunkten 215-zz1°c.After further treatment according to Example 1, after recrystallization from methanol-water, 2.15 g (95%) of pure 5β-O- (α, L-3'-methoxy-ethylramnosido) -14-hydroxy-4,5-epoxy are obtained. bufa-20,22-dienolide with melting points 215-zz1 ° c.
Katalysatorlösningen framställes genom att man löser 0,1 g 1 kresyltitanat i en mätkolv på 25 ml i något absolut dioxan och 2,5 ml av en 0,05 mol/ml titantetrakloridlösning i dioxan ochí påfyller med dioxan till graderingen.The catalyst solution is prepared by dissolving 0.1 g of cresyl titanate in a 25 ml graduated flask in some absolute dioxane and 2.5 ml of a 0,05 mol / ml titanium tetrachloride solution in dioxane and making up to the grade with dioxane.
Exempel 9. 2 g 3ß~O-(a,L-ramnosido-14-hydroxi-bufa-4,20,2Z-tri- enolid löses i 50 ml absolut dioxan och försättes med en lös- ning av 20 ml 3-dimetylaminodiazopropan (0,4 mmol/ml) i eter.Example 9. 2 g of 3β-O- (α, L-ramnosido-14-hydroxy-bufa-4,20,2Z-trienolide are dissolved in 50 ml of absolute dioxane and added with a solution of 20 ml of 3-dimethylaminodiazopropane (0.4 mmol / ml) in ether.
Till lösningen sätter man 4 ml av en lösning av 2-etylhexylti- tanat och titantetraklorid (0,05 mmol 2-etylhexyltitanat och 0,005 mmol titantetraklorid/ml) i absolut dioxan. Efter 17 h vid rumstemperatur vidarebehandlas lösningen enligt exempel 1.To the solution is added 4 ml of a solution of 2-ethylhexyl titanate and titanium tetrachloride (0.05 mmol 2-ethylhexyl titanate and 0.005 mmol titanium tetrachloride / ml) in absolute dioxane. After 17 hours at room temperature, the solution of Example 1 is further treated.
Man erhåller efter omkristallisation ur ättiksyraetylester 2,1 g (94 %) ren SB-O{u,L-3'-(3"-dimetylaminopropyl)-ramnosido]-14- hydroxi-bufa-4,20,Z2-trienolid med smältpunkten 135-1460C.After recrystallization from acetic acid ethyl ester 2.1 g (94%) of pure SB-O {u, L-3 '- (3 "-dimethylaminopropyl) -ramnosido] -14-hydroxy-bufa-4,20, Z2-trienolide with melting point 135 DEG-146 DEG.
Katalysatorlösningen framställes genom att i en mätkolv på och tillsätter 2,5 ml av en titantetrakloridlösning (0,05 mmol/ ml, se ex. 1)_i dioxan och påfyller till graderingen med diokan.The catalyst solution is prepared by adding 2.5 ml of a titanium tetrachloride solution (0.05 mmol / ml, see Example 1) to dioxane in a volumetric flask and making up to the grade with dioxane.
Exempel 10.2 g 36-0-(a,L-ramnosido)-14-hydroxí-bufa-2,20,22-tri- enolid löses i 50 ml absolut dioxan och försättes med 20 ml av en lösning av 2-fenyldiazoetan (0,4 mmol/ml) i eter. Sedan till- sätter man 4 ml av en blandning av etyltitanat (0,05 mmol/ml] och titantetraklorid (0,005 mmol/ml) i absolut dioxan och låter lösningen stå 16 h vid rumstemperatur. Efter vidarebehandling enligt exempel 1 erhåller man efter omkristallisatíon ur ättik- syraetylester 2,2 g (94 %) ren 36-0-EnL-3'-(2"-fenyletyl)-ramno- sido]-14-hydroxi-bufa-4,20,22-tríenolíd med smältpunkten 180 - 19s°c. 10 15 7806564-1 7 Katalysatorlösníngen framställes genom att man löser 0,28 ml etyltitanat i en mätkolv på 25 ml i något absolut díoxan och tillsätter 2,5 ml av en av 0,05 mmol/ml bestående titantet- rakloridlösning i dioxan och påfyller till graderingen med abs. dioxan.Example 10.2 g of 36-O- (α, L-Ramnosido) -14-hydroxy-bufa-2,20,22-trienolide are dissolved in 50 ml of absolute dioxane and added to 20 ml of a solution of 2-phenyldiazoethane (0 , 4 mmol / ml) in ether. Then 4 ml of a mixture of ethyl titanate (0.05 mmol / ml] and titanium tetrachloride (0.005 mmol / ml) in absolute dioxane are added and the solution is allowed to stand for 16 hours at room temperature. After further treatment according to Example 1, after recrystallization from acetic acid ethyl ester 2.2 g (94%) of pure 36-O-EnL-3 '- (2 "-phenylethyl) -ramino-side] -14-hydroxy-bufa-4,20,22-trienolide, m.p. The catalyst solution is prepared by dissolving 0.28 ml of ethyl titanate in a 25 ml graduated flask in some absolute dioxane and adding 2.5 ml of a titanium tetrachloride solution consisting of 0.05 mmol / ml. in dioxane and replenishes to the grade with absolute dioxane.
Exemgel 11. 2 g 36-0-(a,L-ramnosido]-14-hydroxi-bufa-4,20,22- trienolid löses i 50 ml absolut dioxan och försättes med 25 ml av en lösning av díazopropyn (0,3 mmol/ml) i eter och härpå med 4 ml av en blandning av titanacetylacetonat (0,4 %) och titan- tetraklorid (0,005 mmol/ml] i dioxan. Efter 14 h vid rumstempe- ratur och vidarebehandlíng enligt exempel 1 erhåller man efter omkristallisation ur ättiksyraetylester 2,1 g (93 %) ren 35-0- [a,L-3'-(propyn-3")-ramnosido]-14-hydroxi-bufa-4,20,Z2-trieno- iid med smälrpunkten 17o-17s°c Katalysatorblandningen framställes genom att man i en mät- kolv på 25 ml löser 0,1 ml títanacetylacetonat i absolut dioxan och tillsätter 2,5 ml av en av 0,05 mmol/ml bestående titantet- rakloridlösning i absolut äíoxan (se exempel 1) och påfyller till graderíngen med absolut) doxan.Example Gel 11. Dissolve 2 g of 36-O- (α, L-ramnosido] -14-hydroxy-bufa-4,20,22-trienolide in 50 ml of absolute dioxane and add 25 ml of a solution of diazopropyne (0.3 mmol / ml) in ether and then with 4 ml of a mixture of titanium acetylacetonate (0.4%) and titanium tetrachloride (0.005 mmol / ml] in dioxane After 14 hours at room temperature and further treatment according to Example 1, after recrystallization from acetic acid ethyl ester 2.1 g (93%) of pure 35-O- [α, L-3 '- (propyn-3 ") -ramnosido] -14-hydroxy-bufa-4,20, Z2-trienoid with melting point 180 DEG-177 DEG C. The catalyst mixture is prepared by dissolving 0.1 ml of titanium acetylacetonate in absolute dioxane in a 25 ml graduated flask and adding 2.5 ml of a titanium tetrachloride solution consisting of 0.05 mmol / ml of absolute oxane (see example 1) and add to the gradation with absolute) doxan.
Claims (2)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0405677A AT368523B (en) | 1977-06-08 | 1977-06-08 | METHOD FOR PRODUCING BUFADIENOLID AND BUFATRIENOLIDAETHERS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7806364L SE7806364L (en) | 1978-12-09 |
| SE442015B true SE442015B (en) | 1985-11-25 |
Family
ID=3559053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7806364A SE442015B (en) | 1977-06-08 | 1978-05-31 | SET TO MAKE BUFADIENOLID AND BUFATRIENOLIDETERS |
Country Status (17)
| Country | Link |
|---|---|
| JP (1) | JPS5416463A (en) |
| AT (1) | AT368523B (en) |
| BE (1) | BE867944A (en) |
| CA (1) | CA1107720A (en) |
| CH (1) | CH637145A5 (en) |
| DE (1) | DE2824318A1 (en) |
| EG (1) | EG13431A (en) |
| ES (1) | ES470578A2 (en) |
| FI (1) | FI62844C (en) |
| FR (1) | FR2393813A2 (en) |
| GB (1) | GB1601539A (en) |
| IL (1) | IL54850A0 (en) |
| IT (1) | IT1109164B (en) |
| LU (1) | LU79783A1 (en) |
| NL (1) | NL7805797A (en) |
| SE (1) | SE442015B (en) |
| YU (1) | YU40194B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2325467B (en) * | 1997-05-21 | 2000-11-01 | Dainippon Ink & Chemicals | Process for producing material with hydrophilic surface |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1905725A1 (en) * | 1969-02-06 | 1970-08-20 | Boehringer Mannheim Gmbh | Acovenoside A derivatives and processes for making the same |
| DE1910207C3 (en) * | 1969-02-28 | 1978-04-13 | Knoll Ag, 6700 Ludwigshafen | Process for their manufacture |
| DE2404268C2 (en) * | 1974-01-30 | 1982-09-16 | Knoll Ag, 6700 Ludwigshafen | Proscillaridin ethers and process for their preparation |
| AT349159B (en) * | 1974-07-09 | 1979-03-26 | Laevosan Gmbh & Co Kg | PROCESS FOR THE PREPARATION OF NEW BUFADIENOLIDE AND BUFATRIENOLIDE Aethers |
-
1977
- 1977-06-08 AT AT0405677A patent/AT368523B/en not_active IP Right Cessation
-
1978
- 1978-05-23 CH CH557778A patent/CH637145A5/en not_active IP Right Cessation
- 1978-05-26 GB GB22676/78A patent/GB1601539A/en not_active Expired
- 1978-05-29 NL NL7805797A patent/NL7805797A/en not_active Application Discontinuation
- 1978-05-29 YU YU1279/78A patent/YU40194B/en unknown
- 1978-05-31 SE SE7806364A patent/SE442015B/en not_active IP Right Cessation
- 1978-05-31 IT IT24056/78A patent/IT1109164B/en active
- 1978-06-02 IL IL7854850A patent/IL54850A0/en unknown
- 1978-06-02 DE DE19782824318 patent/DE2824318A1/en active Granted
- 1978-06-06 JP JP6733378A patent/JPS5416463A/en active Granted
- 1978-06-06 FR FR787816874A patent/FR2393813A2/en active Granted
- 1978-06-07 ES ES470578A patent/ES470578A2/en not_active Expired
- 1978-06-07 EG EG365/78A patent/EG13431A/en active
- 1978-06-07 CA CA304,930A patent/CA1107720A/en not_active Expired
- 1978-06-07 FI FI781823A patent/FI62844C/en not_active IP Right Cessation
- 1978-06-08 BE BE188429A patent/BE867944A/en not_active IP Right Cessation
- 1978-06-08 LU LU79783A patent/LU79783A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES470578A2 (en) | 1979-04-01 |
| FI62844B (en) | 1982-11-30 |
| DE2824318A1 (en) | 1978-12-21 |
| YU127978A (en) | 1982-10-31 |
| CH637145A5 (en) | 1983-07-15 |
| ATA405677A (en) | 1982-02-15 |
| GB1601539A (en) | 1981-10-28 |
| SE7806364L (en) | 1978-12-09 |
| AT368523B (en) | 1982-10-25 |
| FR2393813A2 (en) | 1979-01-05 |
| YU40194B (en) | 1985-08-31 |
| IT7824056A0 (en) | 1978-05-31 |
| FI781823A7 (en) | 1978-12-09 |
| IT1109164B (en) | 1985-12-16 |
| CA1107720A (en) | 1981-08-25 |
| JPS5416463A (en) | 1979-02-07 |
| LU79783A1 (en) | 1978-11-28 |
| IL54850A0 (en) | 1978-08-31 |
| BE867944A (en) | 1978-10-02 |
| JPS6213359B2 (en) | 1987-03-25 |
| FR2393813B2 (en) | 1982-08-27 |
| FI62844C (en) | 1983-03-10 |
| EG13431A (en) | 1982-06-30 |
| DE2824318C2 (en) | 1987-10-01 |
| NL7805797A (en) | 1978-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102527821B1 (en) | 6.alpha.-alkyl-6,7-dione steroids as intermediates for the production of steroidal fxr modulators | |
| CZ125495A3 (en) | Process for preparing clavulanic acid and salt thereof | |
| RS51892B (en) | DROSPIRENON PREPARATION PROCESS | |
| EP0050325A2 (en) | Process for the preparation of intermediates in the synthesis of vitamin-D3 metabolites, and intermediates | |
| CN102964414A (en) | Synthesis method of 17-position steroid carboxylic ester | |
| SE442015B (en) | SET TO MAKE BUFADIENOLID AND BUFATRIENOLIDETERS | |
| GB1564809A (en) | 24,25-epoxy-cholestane derivatives | |
| ES2954771T3 (en) | Preparation Procedure for High Performance Vascular Leak Blockers | |
| EP0297594A2 (en) | Novel 3',4'-dinitrogen substituted epipodophyllotoxin glucoside derivatives | |
| Andersen et al. | Selective Transformations of the Ca “" Pump Inhibitor Thapsigargin | |
| JPH023797B2 (en) | ||
| CN113372375B (en) | Preparation method of temsirolimus intermediate | |
| CN105237605B (en) | A kind of intermediate and its preparation method and application for synthesizing gestodene | |
| Manson et al. | Preparation of 2-methylene-. DELTA. 4-3-oxo steroids | |
| CN114671890A (en) | Efficient and stable everolimus preparation method | |
| EP0044105B1 (en) | New 8-alpha-oestra-1,3,5(10)-triene derivatives, processes for their preparation and pharmaceutical compositions | |
| EP0072894A1 (en) | Cyano-steroid compound and preparation thereof | |
| EP0124252A2 (en) | Double ester of 16beta-ethylestran-17beta-ol derivatives | |
| US3981862A (en) | Preparation of C22-alkyl derivative of digoxin | |
| US3642826A (en) | 3-oxo-a 19-bis-nor-homo-steroid-5(10)-enes and process for their manufacture | |
| SU944502A3 (en) | Process for producing derivatives of prostaglandin | |
| JPS6152839B2 (en) | ||
| US2519507A (en) | 20, 21-diacetoxy-4-bromo-3, 11-diketopregnanes | |
| US2505837A (en) | 4-bromo-3, 11-diketo-17(alpha)-hydroxy-20-acyloxypregnanes and process | |
| US2915435A (en) | 16-fluoro-3-keto-17beta-(alpha, beta-oxido-propanoyl)-delta4-androstenes and derivatives thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 7806364-1 Effective date: 19880318 Format of ref document f/p: F |